Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
|Articles|May 1, 2011
Drug Topics, Digital Edition, May 2011
REMS Update : Solutions for REMS implementation in hospital and retail settings Creating an informational home pharmacy Doug Hoey talks about his goals for NCPA The case for call centers Managing clopidogrel hypersensitivity
Advertisement
Advertisement
Related to this article
Study findings tie continuous glucose monitoring measures to elevated cardiovascular risk in adults without diabetes.
The once daily tablet is expected to reach US patients in October 2026.
The label expansion adds patients 12 years of age and older to the once daily alopecia areata indication.
Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves AbbVie's Juvmo for Parkinson Disease
2
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
3
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
4
Why Pharmacy is a Cornerstone of Public Health in the US
5